Skip to main content
NVDA-2.33%AAPL+3.12%GOOGL+0.37%MSFT+0.13%AMZN-0.10%TSM-1.05%SPCX+2.07%AVGO-0.48%META-0.84%TSLA-0.44%SKHY-3.77%MU-4.62%BRK-B-0.27%LLY+0.45%JPM-0.57%WMT+0.03%AMD-3.08%V-0.15%XOM+0.59%ASMLa-1.66%JNJ-0.10%INTC-4.85%MA-0.51%0700.HK-1.94%1398.HK+0.79%ORCL-3.65%ABBV+0.51%BAC-0.55%CSCO-1.25%CVX-0.29%COST-0.30%KO+0.61%LRCX-4.70%CAT-1.57%AP2d-1.55%0005.HK-0.78%AMAT-2.38%UNH-0.62%HSBA.L-1.30%DELL-3.68%PG+0.23%MS-0.91%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.58%0939.HK+1.66%GS-0.91%NZDJPY-2.56%AUDJPY-1.81%CHFJPY-1.60%NZDCAD-1.40%EURNZD+1.40%GBPNZD+1.36%NZDUSD-1.31%USDJPY-1.29%GBPJPY-1.22%EURJPY-1.22%CADJPY-1.18%NZDCHF-1.00%USDZAR+0.93%USDNOK+0.84%EURZAR+0.83%USDSEK+0.82%AUDNZD+0.78%GBPZAR+0.76%EURNOK+0.74%EURSEK+0.71%AUDCAD-0.66%AUDDKK-0.63%EURAUD+0.61%GBPAUD+0.58%CHFNOK+0.57%USDTHB+0.56%CHFSEK+0.55%AUDUSD-0.54%AUDSGD-0.51%USDMXN+0.43%GBPTRY+0.41%CADCHF+0.40%NOKJPY-0.39%EURCHF+0.38%GBPCHF+0.36%NZDSGD-0.36%USDPLN+0.35%USDCHF+0.32%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.25%SGDJPY+0.23%USDSGD+0.22%AUDCHF-0.22%NZDMXN-0.17%USDILS+0.16%EURSGD+0.12%EURHKD-0.11%USDTRY+0.11%PLNJPY+0.11%USDDKK+0.11%AUDNOK+0.10%USDCAD-0.09%EURCZK-0.09%USDCNH+0.09%EURUSD+0.06%GBPUSD+0.06%GBPCAD-0.05%GBPSGD+0.05%CHFSGD-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP+0.02%USDHKD+0.01%EURCNH0.00%EURDKK0.00%XPTUSD-5.60%UKOIL+5.27%USOIL+4.94%HG1-4.78%GAGUSD-4.56%XAGUSD-4.56%GAUUSD-1.03%XAUUSD-1.03%XNGUSD+0.99%COTTON+0.72%S1+0.67%W1+0.56%BTCUSD-1.18%ETHUSD+0.03%USDTUSD-0.03%XRPUSD-2.45%SOLUSD-1.45%TRXUSDT+0.24%ZECUSDT-7.22%DOGEUSD-2.57%XMRUSDT-0.30%LINKUSD-0.93%XLMUSD-1.29%BCHUSDT-9.87%LTCUSD-1.49%UNIUSD-1.22%TONUSD+24.88%HBARUSDT-2.14%SUIUSD-3.57%TAOUSDT-4.58%AAVEUSD-2.14%DOTUSDT-1.20%ICPUSDT-1.26%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.03%ARBUSDT+0.12%JUPUSDT-3.82%INJUSDT-2.63%STXUSDT-3.43%FETUSDT-2.98%TIAUSDT-0.60%PYTHUSDT-0.94%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-2.81%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.28%IOTAUSDT-3.30%AXSUSDT-2.04%FARTCOINUSDT-3.53%EOSUSDT-2.41%DYDXUSDT-1.85%ORDIUSDT-0.60%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.33%AAPL+3.12%GOOGL+0.37%MSFT+0.13%AMZN-0.10%TSM-1.05%SPCX+2.07%AVGO-0.48%META-0.84%TSLA-0.44%SKHY-3.77%MU-4.62%BRK-B-0.27%LLY+0.45%JPM-0.57%WMT+0.03%AMD-3.08%V-0.15%XOM+0.59%ASMLa-1.66%JNJ-0.10%INTC-4.85%MA-0.51%0700.HK-1.94%1398.HK+0.79%ORCL-3.65%ABBV+0.51%BAC-0.55%CSCO-1.25%CVX-0.29%COST-0.30%KO+0.61%LRCX-4.70%CAT-1.57%AP2d-1.55%0005.HK-0.78%AMAT-2.38%UNH-0.62%HSBA.L-1.30%DELL-3.68%PG+0.23%MS-0.91%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.58%0939.HK+1.66%GS-0.91%NZDJPY-2.56%AUDJPY-1.81%CHFJPY-1.60%NZDCAD-1.40%EURNZD+1.40%GBPNZD+1.36%NZDUSD-1.31%USDJPY-1.29%GBPJPY-1.22%EURJPY-1.22%CADJPY-1.18%NZDCHF-1.00%USDZAR+0.93%USDNOK+0.84%EURZAR+0.83%USDSEK+0.82%AUDNZD+0.78%GBPZAR+0.76%EURNOK+0.74%EURSEK+0.71%AUDCAD-0.66%AUDDKK-0.63%EURAUD+0.61%GBPAUD+0.58%CHFNOK+0.57%USDTHB+0.56%CHFSEK+0.55%AUDUSD-0.54%AUDSGD-0.51%USDMXN+0.43%GBPTRY+0.41%CADCHF+0.40%NOKJPY-0.39%EURCHF+0.38%GBPCHF+0.36%NZDSGD-0.36%USDPLN+0.35%USDCHF+0.32%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.25%SGDJPY+0.23%USDSGD+0.22%AUDCHF-0.22%NZDMXN-0.17%USDILS+0.16%EURSGD+0.12%EURHKD-0.11%USDTRY+0.11%PLNJPY+0.11%USDDKK+0.11%AUDNOK+0.10%USDCAD-0.09%EURCZK-0.09%USDCNH+0.09%EURUSD+0.06%GBPUSD+0.06%GBPCAD-0.05%GBPSGD+0.05%CHFSGD-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP+0.02%USDHKD+0.01%EURCNH0.00%EURDKK0.00%XPTUSD-5.60%UKOIL+5.27%USOIL+4.94%HG1-4.78%GAGUSD-4.56%XAGUSD-4.56%GAUUSD-1.03%XAUUSD-1.03%XNGUSD+0.99%COTTON+0.72%S1+0.67%W1+0.56%BTCUSD-1.18%ETHUSD+0.03%USDTUSD-0.03%XRPUSD-2.45%SOLUSD-1.45%TRXUSDT+0.24%ZECUSDT-7.22%DOGEUSD-2.57%XMRUSDT-0.30%LINKUSD-0.93%XLMUSD-1.29%BCHUSDT-9.87%LTCUSD-1.49%UNIUSD-1.22%TONUSD+24.88%HBARUSDT-2.14%SUIUSD-3.57%TAOUSDT-4.58%AAVEUSD-2.14%DOTUSDT-1.20%ICPUSDT-1.26%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.03%ARBUSDT+0.12%JUPUSDT-3.82%INJUSDT-2.63%STXUSDT-3.43%FETUSDT-2.98%TIAUSDT-0.60%PYTHUSDT-0.94%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-2.81%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.28%IOTAUSDT-3.30%AXSUSDT-2.04%FARTCOINUSDT-3.53%EOSUSDT-2.41%DYDXUSDT-1.85%ORDIUSDT-0.60%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
OM

OmniAb, Inc. (OABI)

NASDAQ • Healthcare

$4.01
-$0.23 (-5.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$4.21
Previous Close$4.01
Day Range$3.97 - $4.27
Avg. Volume (3M)2.5M
Market Cap$580.6M
52 Week Range
$1.3$5.43
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$13.4M100%
Gross Profitminus cost of goods$12.8M95%

In plain terms: out of every $100 in revenue, OmniAb, Inc. currently loses $44.

Fundamentals & Financials

Revenue (TTM)
$38.4M
Net Income (TTM)
-$44.2M
EPS (TTM)
-$0.36
ROA (TTM)
-15.25%
Current Ratio
4.8

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-37.5%Q1 2026-$0.11
+40.0%Q2 2026-$0.06
+58.3%Q3 2026-$0.05
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About OmniAb, Inc.

OmniAb, Inc. is a NASDAQ-listed biotechnology company focused on therapeutic antibody discovery through engineered-animal platforms and screening tools that help partners generate human-sequence antibodies and related candidates for human therapeutics. In FY2025, it recorded $18.7 million in revenue through this platform-based discovery business.

Name
OmniAb, Inc.
CEO
Matthew W. Foehr
Website
www.omniab.com
Industry
Healthcare
Year Founded
2012
Employees
89

Today's Snapshot

AI-generated

OABI is trading 0.8% below yesterday's close, while its sector was flat.

Trading Volume

Below 10d avg (1.6M)

309.5K

vs S&P 500 Today

Moderate Underperformance

-0.19%

Updated: September 10, 2026 at 16:54 UTC

Technical Indicators

4 Buy2 Neutral2 Sell
OABI’s technical picture is constructive on a medium-to-longer-term basis despite a short-term pullback. A strong ADX points to a pronounced trend, and the stock sits above the 50/100/200-day averages, indicating broader bullish positioning even though the 10- and 20-day averages are currently higher than the price. Momentum oscillators show oversold readings on the stochastic and Williams %R, while MACD and RSI are neutral, and on-balance volume is strongly positive, supporting the trend. Volatility is elevated, but overall signals skew to the upside. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$2.38 - $4.30
    Buy
  • RSI (14)52.51
    Neutral
  • Stochastic %K (14, 3, 3)11.73
    Buy
  • MACD Level (12, 26)0.35
    Neutral

Peers & Related Assets

CDXSCodexis, Inc.
$1.430.0%
CCCCC4 Therapeutics, Inc.
IVVDInvivyd, Inc.
TARAProtara Therapeutics, Inc.
ARMPArmata Pharmaceuticals, Inc.
IPHAInnate Pharma S.A.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.